Public health threats can arise anywhere, at any time, making global readiness more critical than ever. For over 25 years, Emergent has been at the forefront of preparedness, working hand in hand with governments and agencies to deliver products that protect against some of the world’s most pressing health threats, including botulism, Ebola, smallpox, mpox, and anthrax.
The world is more interconnected today than ever before. Disease and other problems can spread quickly. Recent events have demonstrated the importance of strong collaboration between governments, industry, and civil society. Whether the threat is an emerging infectious disease or an intentional biological attack, countries need to be prepared in advance, so they can quickly respond when an event occurs.
At Emergent, we work with our partners to understand threats of concern, build sustainable strategies to respond if and when necessary, and help prioritize stockpiling needs. Partnerships between industry and governments allow individual nations to be better prepared to respond to threats, enabling them to rely less on international agencies for products and expertise.
One element of resilient preparedness is stockpiling medical countermeasures. Stockpiling medical countermeasures is fundamental to an effective preparedness strategy. Maintaining a reliable, long-term stockpile of vaccines, therapeutics, and other emergency health resources ensures that governments have access to necessary medical countermeasures when they need them, supporting response readiness and helping to mitigate the risk of supply chain disruptions in times of crisis.
When considering strategic stockpiling, it’s important to invest in a diversified portfolio of countermeasures. Preparing for biological threats requires more than one type of solution – future events could demand a mix of vaccines, therapeutics, and rapid diagnostic capabilities. By broadening investment to cover a variety of medical technologies, countries can maintain a robust response capability, regardless of the nature of the threat.
Prioritizing long-term preparedness is a crucial investment in safeguarding global health. As the world continues to face evolving threats, it’s imperative that governments and industries work together to build robust, responsive frameworks that are ready to respond to the next public health emergency effectively and with resilience.